Drugs / pronase
pronase
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01643785 | Jun 2012 → Jun 2013 | Helicobacter pylori infectious disease | Chuncheon Sacred Heart Hospital | Terminated | No outcome recorded |
| — | NCT01645761 | Jun 2012 → Aug 2013 | gastric ulcer | Chuncheon Sacred Heart Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pronase | “plus 20,000 units of pronase (endonase), BID for 7 days” NCT01643785 ↗ |
| Known as | Brand name: Endonase | “Brand name: Endonase” NCT01643785 ↗ |
| Known as | Endonase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01643785 ↗ |
| Modality | Protein / enzyme biologic | “a kind of protease” NCT01645761 ↗ |